| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatase activity | 1.35e-04 | 287 | 35 | 5 | GO:0016791 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 5.30e-04 | 386 | 35 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.56e-04 | 20 | 35 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 6.09e-04 | 398 | 35 | 5 | GO:0061659 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.81e-03 | 36 | 35 | 2 | GO:0019789 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.87e-03 | 512 | 35 | 5 | GO:0019787 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.08e-03 | 775 | 35 | 6 | GO:0016746 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 2.21e-03 | 532 | 35 | 5 | GO:0016755 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 2.55e-03 | 807 | 35 | 6 | GO:0016788 | |
| GeneOntologyMolecularFunction | tau protein binding | 2.94e-03 | 46 | 35 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.94e-03 | 46 | 35 | 2 | GO:0004715 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 4.37e-03 | 189 | 35 | 3 | GO:0004721 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.12e-03 | 61 | 35 | 2 | GO:0030374 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule binding | 2.79e-05 | 5 | 35 | 2 | GO:1904528 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 3.65e-04 | 17 | 35 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 4.10e-04 | 18 | 35 | 2 | GO:0000159 | |
| Domain | zf-MIZ | 7.12e-05 | 7 | 35 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 7.12e-05 | 7 | 35 | 2 | PS51044 | |
| Domain | Znf_MIZ | 9.49e-05 | 8 | 35 | 2 | IPR004181 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 2.63e-04 | 13 | 35 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 2.63e-04 | 13 | 35 | 2 | PS00125 | |
| Domain | PP2Ac | 2.63e-04 | 13 | 35 | 2 | SM00156 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.25e-03 | 28 | 35 | 2 | IPR004843 | |
| Domain | Metallophos | 1.25e-03 | 28 | 35 | 2 | PF00149 | |
| Domain | - | 1.41e-03 | 449 | 35 | 5 | 3.30.40.10 | |
| Domain | Metallo-depent_PP-like | 1.44e-03 | 30 | 35 | 2 | IPR029052 | |
| Domain | - | 1.44e-03 | 30 | 35 | 2 | 3.60.21.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.55e-03 | 459 | 35 | 5 | IPR013083 | |
| Domain | SH3_1 | 3.54e-03 | 164 | 35 | 3 | PF00018 | |
| Domain | SH3 | 7.60e-03 | 216 | 35 | 3 | PS50002 | |
| Domain | SH3 | 7.60e-03 | 216 | 35 | 3 | SM00326 | |
| Domain | SH3_domain | 7.99e-03 | 220 | 35 | 3 | IPR001452 | |
| Domain | SH3_9 | 9.37e-03 | 78 | 35 | 2 | PF14604 | |
| Domain | TyrKc | 1.18e-02 | 88 | 35 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.18e-02 | 88 | 35 | 2 | IPR020635 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 5.36e-05 | 110 | 27 | 4 | M48043 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 7.38e-05 | 7 | 27 | 2 | M26992 | |
| Pathway | REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION | 1.57e-04 | 10 | 27 | 2 | M27176 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 1.57e-04 | 10 | 27 | 2 | MM14509 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.30e-04 | 12 | 27 | 2 | M27950 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 2.72e-04 | 13 | 27 | 2 | M1015 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 2.72e-04 | 13 | 27 | 2 | MM14811 | |
| Pathway | WP_DOPAMINE_METABOLISM | 2.72e-04 | 13 | 27 | 2 | M39622 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 2.72e-04 | 13 | 27 | 2 | M8410 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 3.65e-04 | 15 | 27 | 2 | M27407 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.01e-04 | 76 | 27 | 3 | MM15051 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 4.17e-04 | 16 | 27 | 2 | M47870 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 4.17e-04 | 16 | 27 | 2 | MM14699 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 4.17e-04 | 16 | 27 | 2 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 4.17e-04 | 16 | 27 | 2 | M514 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 4.72e-04 | 17 | 27 | 2 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 4.72e-04 | 17 | 27 | 2 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 4.72e-04 | 17 | 27 | 2 | M919 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 5.30e-04 | 18 | 27 | 2 | MM14759 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 5.77e-04 | 86 | 27 | 3 | M916 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M47525 | |
| Pathway | WP_HYPOXIADEPENDENT_PROLIFERATION_OF_MYOBLASTS | 5.92e-04 | 19 | 27 | 2 | MM15811 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 5.92e-04 | 19 | 27 | 2 | MM14780 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 6.57e-04 | 20 | 27 | 2 | MM1437 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 6.57e-04 | 20 | 27 | 2 | M47876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 7.25e-04 | 21 | 27 | 2 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 7.25e-04 | 21 | 27 | 2 | MM14996 | |
| Pathway | REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION | 7.97e-04 | 22 | 27 | 2 | M6768 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 7.97e-04 | 22 | 27 | 2 | M16563 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 7.97e-04 | 22 | 27 | 2 | M47919 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 7.97e-04 | 22 | 27 | 2 | M13408 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 9.50e-04 | 24 | 27 | 2 | M751 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.03e-03 | 25 | 27 | 2 | MM15379 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.03e-03 | 25 | 27 | 2 | M808 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.05e-03 | 418 | 27 | 5 | MM15587 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.12e-03 | 108 | 27 | 3 | M17034 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 1.20e-03 | 27 | 27 | 2 | M287 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.20e-03 | 27 | 27 | 2 | MM14779 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.27e-03 | 252 | 27 | 4 | MM15585 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.27e-03 | 113 | 27 | 3 | MM14783 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.29e-03 | 28 | 27 | 2 | MM15132 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 1.29e-03 | 28 | 27 | 2 | MM1391 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.39e-03 | 29 | 27 | 2 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.39e-03 | 29 | 27 | 2 | MM15253 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.44e-03 | 118 | 27 | 3 | M713 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.59e-03 | 31 | 27 | 2 | M27400 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.59e-03 | 31 | 27 | 2 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.59e-03 | 31 | 27 | 2 | MM15254 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.59e-03 | 31 | 27 | 2 | MM15154 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.59e-03 | 31 | 27 | 2 | M15195 | |
| Pathway | WP_MONOAMINE_TRANSPORT | 1.69e-03 | 32 | 27 | 2 | M39724 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 1.80e-03 | 33 | 27 | 2 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 1.80e-03 | 33 | 27 | 2 | MM15252 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.91e-03 | 34 | 27 | 2 | M27405 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 1.91e-03 | 34 | 27 | 2 | M27527 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.91e-03 | 34 | 27 | 2 | M27556 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.91e-03 | 34 | 27 | 2 | MM15985 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.91e-03 | 34 | 27 | 2 | M42555 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.02e-03 | 35 | 27 | 2 | MM15271 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.07e-03 | 288 | 27 | 4 | M16864 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 2.14e-03 | 36 | 27 | 2 | MM15339 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 2.26e-03 | 37 | 27 | 2 | M27641 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.46e-03 | 302 | 27 | 4 | M39719 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 2.51e-03 | 39 | 27 | 2 | MM15257 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.52e-03 | 304 | 27 | 4 | MM14960 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.63e-03 | 40 | 27 | 2 | M39595 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 2.63e-03 | 40 | 27 | 2 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 2.63e-03 | 40 | 27 | 2 | MM15258 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 2.77e-03 | 41 | 27 | 2 | M27533 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 2.77e-03 | 41 | 27 | 2 | M232 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 2.77e-03 | 41 | 27 | 2 | M27257 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.80e-03 | 313 | 27 | 4 | M27867 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 2.90e-03 | 42 | 27 | 2 | MM15274 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 3.04e-03 | 43 | 27 | 2 | M27560 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.04e-03 | 532 | 27 | 5 | M27870 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.13e-03 | 323 | 27 | 4 | M27080 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 3.18e-03 | 44 | 27 | 2 | MM15377 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.24e-03 | 326 | 27 | 4 | MM15917 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.26e-03 | 157 | 27 | 3 | MM15226 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.44e-03 | 160 | 27 | 3 | M27498 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 3.62e-03 | 47 | 27 | 2 | M29724 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 3.62e-03 | 47 | 27 | 2 | M39518 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.72e-03 | 339 | 27 | 4 | M39736 | |
| Pathway | WP_EXERCISEINDUCED_CIRCADIAN_REGULATION | 3.77e-03 | 48 | 27 | 2 | M39444 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 3.77e-03 | 48 | 27 | 2 | MM14696 | |
| Pathway | WP_EXERCISEINDUCED_CIRCADIAN_REGULATION | 3.93e-03 | 49 | 27 | 2 | MM15870 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 4.09e-03 | 50 | 27 | 2 | M678 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 4.09e-03 | 50 | 27 | 2 | MM15255 | |
| Pathway | REACTOME_HEMOSTASIS | 4.12e-03 | 571 | 27 | 5 | MM14472 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 4.42e-03 | 52 | 27 | 2 | M27530 | |
| Pathway | PID_AR_TF_PATHWAY | 4.58e-03 | 53 | 27 | 2 | M151 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.61e-03 | 360 | 27 | 4 | M27267 | |
| Pathway | PID_TGFBR_PATHWAY | 4.75e-03 | 54 | 27 | 2 | M286 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 5.65e-03 | 59 | 27 | 2 | MM15128 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 6.03e-03 | 61 | 27 | 2 | M152 | |
| Pathway | PID_AR_PATHWAY | 6.03e-03 | 61 | 27 | 2 | M58 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2 | 6.22e-03 | 62 | 27 | 2 | MM15256 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 6.42e-03 | 63 | 27 | 2 | MM14714 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.03e-03 | 66 | 27 | 2 | MM17074 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 7.03e-03 | 66 | 27 | 2 | MM14990 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 9.84e-07 | 2 | 35 | 2 | 2837763 | |
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 9.84e-07 | 2 | 35 | 2 | 1846293 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 9.84e-07 | 2 | 35 | 2 | 2555176 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 9.84e-07 | 2 | 35 | 2 | 27096707 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18053775 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10543450 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11751260 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11113010 | ||
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 9.84e-07 | 2 | 35 | 2 | 34902541 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 7510677 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 2.95e-06 | 3 | 35 | 2 | 8206937 | |
| Pubmed | The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. | 2.95e-06 | 3 | 35 | 2 | 17584785 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 2.95e-06 | 3 | 35 | 2 | 23341017 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 8383590 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15252037 | ||
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 5.90e-06 | 4 | 35 | 2 | 21998041 | |
| Pubmed | Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. | 5.90e-06 | 4 | 35 | 2 | 9770493 | |
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 5.90e-06 | 4 | 35 | 2 | 7616230 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9920888 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 11371618 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 21454489 | ||
| Pubmed | The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. | 5.90e-06 | 4 | 35 | 2 | 14633983 | |
| Pubmed | Sexually dimorphic gene expression of the Zimp7 and Zimp10 genes in embryonic gonads. | 9.82e-06 | 5 | 35 | 2 | 19931425 | |
| Pubmed | Identification of proteins interacting with the catalytic subunit of PP2A by proteomics. | 9.82e-06 | 5 | 35 | 2 | 17163575 | |
| Pubmed | The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. | 9.82e-06 | 5 | 35 | 2 | 16777850 | |
| Pubmed | HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. | 9.82e-06 | 5 | 35 | 2 | 9009195 | |
| Pubmed | Protein phosphatase 2A interacts with and directly dephosphorylates RelA. | 9.82e-06 | 5 | 35 | 2 | 11591705 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 10640627 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 18596935 | ||
| Pubmed | Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. | 1.04e-05 | 42 | 35 | 3 | 29028833 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 10781942 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 20100830 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 29735529 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 9647778 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 15147202 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 20159969 | ||
| Pubmed | STRIPAK components determine mode of cancer cell migration and metastasis. | 1.47e-05 | 6 | 35 | 2 | 25531779 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 10698523 | ||
| Pubmed | Protein phosphatase 2A and separase form a complex regulated by separase autocleavage. | 2.06e-05 | 7 | 35 | 2 | 17604273 | |
| Pubmed | The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development. | 2.06e-05 | 7 | 35 | 2 | 25546391 | |
| Pubmed | X-linked microtubule-associated protein, Mid1, regulates axon development. | 2.06e-05 | 7 | 35 | 2 | 24194544 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 1330687 | ||
| Pubmed | Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. | 2.74e-05 | 8 | 35 | 2 | 11007961 | |
| Pubmed | Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. | 2.74e-05 | 8 | 35 | 2 | 12912990 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 16262633 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 35768646 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 12370081 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 23462102 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 18432318 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 12885400 | ||
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 4.40e-05 | 10 | 35 | 2 | 15048123 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 22442484 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 11259605 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 34079065 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 12435421 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 18971272 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 21072166 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 16717086 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 8.89e-05 | 14 | 35 | 2 | 9013886 | |
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 9400615 | ||
| Pubmed | 1.02e-04 | 15 | 35 | 2 | 38474134 | ||
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 23047923 | ||
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 1.33e-04 | 17 | 35 | 2 | 21351466 | |
| Pubmed | 1.49e-04 | 18 | 35 | 2 | 23287597 | ||
| Pubmed | A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. | 1.49e-04 | 18 | 35 | 2 | 16085932 | |
| Pubmed | 1.66e-04 | 19 | 35 | 2 | 32582689 | ||
| Pubmed | Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation. | 1.66e-04 | 19 | 35 | 2 | 26389696 | |
| Pubmed | Shugoshin collaborates with protein phosphatase 2A to protect cohesin. | 1.66e-04 | 19 | 35 | 2 | 16541025 | |
| Pubmed | 1.85e-04 | 20 | 35 | 2 | 21514445 | ||
| Pubmed | Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. | 2.46e-04 | 23 | 35 | 2 | 26644582 | |
| Pubmed | Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis. | 2.91e-04 | 25 | 35 | 2 | 26393505 | |
| Pubmed | 2.91e-04 | 25 | 35 | 2 | 34004147 | ||
| Pubmed | 3.15e-04 | 26 | 35 | 2 | 11531413 | ||
| Pubmed | 3.49e-04 | 136 | 35 | 3 | 25429064 | ||
| Pubmed | 3.66e-04 | 28 | 35 | 2 | 18067320 | ||
| Pubmed | 6.07e-04 | 36 | 35 | 2 | 22422068 | ||
| Pubmed | Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation. | 6.41e-04 | 37 | 35 | 2 | 26811472 | |
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 6.41e-04 | 37 | 35 | 2 | 32133736 | |
| Pubmed | Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. | 7.12e-04 | 39 | 35 | 2 | 24703692 | |
| Pubmed | 7.49e-04 | 40 | 35 | 2 | 23555304 | ||
| Pubmed | 7.49e-04 | 40 | 35 | 2 | 28386764 | ||
| Pubmed | 8.26e-04 | 42 | 35 | 2 | 27780869 | ||
| Pubmed | 8.91e-04 | 430 | 35 | 4 | 32581705 | ||
| Pubmed | 9.06e-04 | 44 | 35 | 2 | 23070814 | ||
| Pubmed | Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. | 9.06e-04 | 44 | 35 | 2 | 26075897 | |
| Pubmed | 9.78e-04 | 441 | 35 | 4 | 12853948 | ||
| Pubmed | 9.90e-04 | 46 | 35 | 2 | 18782753 | ||
| GeneFamily | Zinc fingers MIZ-type | 2.96e-05 | 7 | 22 | 2 | 85 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.09e-04 | 13 | 22 | 2 | 693 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.65e-04 | 20 | 22 | 2 | 1371 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 180 | 35 | 4 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 182 | 35 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 185 | 35 | 4 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 185 | 35 | 4 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-05 | 197 | 35 | 4 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | d4161fcbbe47236aac4a077c0994887e765b0b47 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 0d0c69758370d3c44ffe6640e332b6118fc5ce58 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | c546fa80876640bd57a5252df611977009bef9e8 | |
| ToppCell | (08)_PNEC-(4)_1wkpi|(08)_PNEC / shred by cell type and Timepoint | 3.86e-05 | 12 | 35 | 2 | f1b105bcdbe03be6765c820b42c752a24d502212 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 90 | 35 | 3 | 27865bd63dda0624e62a3b713464a490b588d3ae | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 90 | 35 | 3 | 8c2eb7444f938faade7c81a60c004252d588c80b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 90 | 35 | 3 | 4bc53b521abb79fc53ac912f1dc2e3c55426b2e0 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.38e-04 | 128 | 35 | 3 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 142 | 35 | 3 | a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 142 | 35 | 3 | 70f8c1be134835e0d21e6d426b7122f0f5d3d3e5 | |
| ToppCell | Control-Hematopoietic_Mast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 142 | 35 | 3 | db9b7acbab730ae391a362f1ca8177507e52250d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 145 | 35 | 3 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 149 | 35 | 3 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 149 | 35 | 3 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.33e-04 | 153 | 35 | 3 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | IIH-CD8-memory_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.47e-04 | 156 | 35 | 3 | e312fc4317d966fb2b570d1a4a3aa865f781ea93 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-04 | 160 | 35 | 3 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-04 | 164 | 35 | 3 | c721047f1b7abc0d0a3e14bdaabd1a7181231b94 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-04 | 165 | 35 | 3 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-04 | 168 | 35 | 3 | 2eed7dc1a2aff11be024823c4323c42bc94362f6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-04 | 168 | 35 | 3 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 18ba8fc2ba8838484d3b223428cd41568e2ccb10 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 47a63afd80cb7ba2258ba57d3084d8b2a7bc4e8d | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 169 | 35 | 3 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 169 | 35 | 3 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_Naive|Int-URO / Disease, Lineage and Cell Type | 3.17e-04 | 170 | 35 | 3 | 577915dd1f5c418b9b98a7a7153e2b5d1b93ca84 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-04 | 170 | 35 | 3 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-04 | 170 | 35 | 3 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-04 | 171 | 35 | 3 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-04 | 171 | 35 | 3 | a0462781d22c391b3c6c8a72586c385ac089ca5d | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-04 | 171 | 35 | 3 | 85b655dc8a3cbf0e8097e951116490e326a795ac | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | f12c2e48637b96557afbc2006a3a23ba21b7951e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | 12c98dea7370377695c5d22309f78ba03e282a0e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-04 | 171 | 35 | 3 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 35 | 3 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 35 | 3 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-04 | 173 | 35 | 3 | 42272af45547422ef85e35f4a4c7d269e9ed7a8a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 173 | 35 | 3 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 173 | 35 | 3 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-04 | 174 | 35 | 3 | 5c69447261c5aa309a24882656da90655728d637 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 175 | 35 | 3 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 175 | 35 | 3 | 849d8b09b19c10433d1a6a7c75e1f4e08b550954 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 175 | 35 | 3 | 02c67a10cbe849fbf38f082f42517e42483e8cb7 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-04 | 175 | 35 | 3 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-04 | 176 | 35 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 178 | 35 | 3 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 178 | 35 | 3 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 178 | 35 | 3 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.87e-04 | 182 | 35 | 3 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 302bd0f1f8025f385a764f2a9adafdd7f1f67ea3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 183 | 35 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.00e-04 | 184 | 35 | 3 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 2f103ce2427f9cf2c1fafb6bd6045c5863a47549 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 186 | 35 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-04 | 187 | 35 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.19e-04 | 187 | 35 | 3 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.26e-04 | 188 | 35 | 3 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 4.26e-04 | 188 | 35 | 3 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-04 | 188 | 35 | 3 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-04 | 189 | 35 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-04 | 189 | 35 | 3 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.39e-04 | 190 | 35 | 3 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| Disease | Global developmental delay | 1.65e-05 | 133 | 34 | 4 | C0557874 | |
| Disease | Seizures | 1.13e-04 | 218 | 34 | 4 | C0036572 | |
| Disease | mean platelet volume | 1.37e-04 | 1020 | 34 | 7 | EFO_0004584 | |
| Disease | Muscle hypotonia | 1.73e-04 | 17 | 34 | 2 | C0026827 | |
| Disease | Feeding difficulties | 1.95e-04 | 18 | 34 | 2 | C0232466 | |
| Disease | alpha-tocopherol measurement | 2.42e-04 | 20 | 34 | 2 | EFO_0007898 | |
| Disease | Gastric Adenocarcinoma | 1.24e-03 | 45 | 34 | 2 | C0278701 | |
| Disease | Neuroblastoma | 1.35e-03 | 47 | 34 | 2 | C0027819 | |
| Disease | generalised epilepsy | 1.65e-03 | 52 | 34 | 2 | EFO_0005917 | |
| Disease | Headache | 2.48e-03 | 64 | 34 | 2 | HP_0002315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HNHIFWTLPHEYCAM | 331 | Q9H993 | |
| YCNMTADAAWTVVQH | 621 | Q9BZ76 | |
| HNYDVTPLQWMACAN | 431 | Q9NY47 | |
| PQVSKSWHNYMCNEV | 241 | O94805 | |
| IISFFVCWMPYHIHQ | 251 | Q49SQ1 | |
| CPQDIYNVMVQCWAH | 356 | Q07912 | |
| WLQDEMAFCYTQAPH | 356 | Q6TGC4 | |
| CEKHSQPWQVAVYSH | 31 | P20151 | |
| CLAHMAELNPHWHAY | 281 | P78333 | |
| HFLQVMYPKLCQHWQ | 831 | Q9Y6F6 | |
| NHFWCQEEPEPAHMI | 51 | Q13113 | |
| CQRWDSQYPHEHDMT | 326 | P14210 | |
| HQLVMEGYNWCHDRN | 241 | P62714 | |
| HQLVMEGYNWCHDRN | 241 | P67775 | |
| CFSINYVPNMVVWEH | 686 | Q9Y2A7 | |
| YIWRQDQGCHTTMEH | 221 | Q9HB03 | |
| AAVWYYHHCQDRMPI | 146 | Q8TF46 | |
| DVMHHYWVEGNCPTK | 306 | Q9Y6T7 | |
| ALYWACMKVSHPVQN | 261 | Q86T03 | |
| VDAQNICHVWHMNVE | 51 | Q86T96 | |
| HVYQIMNHCWKERPE | 586 | Q08881 | |
| WMYPSRSDHSNCHNI | 236 | A2RUB1 | |
| AVMNHHVCPVENWSY | 26 | Q86TG1 | |
| LPHTCHDFWQMVWEQ | 986 | Q15678 | |
| AINRAPMNGHCHLWY | 251 | Q96LZ7 | |
| YSMPLTSIQCWHVHC | 521 | Q5VTB9 | |
| NEHWMPVYHLCQPCA | 276 | Q8NCH0 | |
| VMCSHFAQDVWPEHS | 76 | Q03936 | |
| CYHHEDRQMNTNWPA | 471 | Q8NF64 | |
| QHHWIVDNMPVTWCY | 151 | Q99805 | |
| VQKFTPSHMFWNCNH | 246 | A2RU30 | |
| IMHAHCWQRYFDSVQ | 1171 | Q8IWV8 | |
| KCYHHEDRQMNTNWP | 611 | Q9ULJ6 | |
| FTYCWHDDIMQAVFH | 1606 | P49815 | |
| IDYRNYLHQWMCHPD | 4321 | P20929 | |
| YLHQWMCHPDQNDVI | 4326 | P20929 |